<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">

<html>

	<head>
		<title>Untitled Page</title>
	</head>

	<body bgcolor="#ffffff">
		<br>
		<br>
		<br>
		<br>
		<div align="center">
			<p>SECURITIES AND EXCHANGE COMMISSION<br>
				WASHINGTON, D.C. 20549<br>
				<br>
				_________________<br>
				<br>
				FORM 8-K<br>
				_________________<br>
				<br>
				CURRENT REPORT<br>
				<br>
				PURSUANT TO SECTION 13 OR 15(D) OF<br>
				THE SECURITIES EXCHANGE ACT OF 1934<br>
				<br>Date of Report (Date of earliest event reported): January 8, 2007<br>
				<br>
				<br>
				<u>BODYTEL SCIENTIFIC INC.</u><br>
				(Exact Name of Registrant as Specified in Its Charter)<br>
				<br>
				<u>Nevada</u><br>
				(State or Other Jurisdiction of Incorporation)<br>
				<br>
				&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>000-51633</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;<u>98-0461698</u><br>
				&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Commission File Number)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (IRS Employer Identification No.)<br>
				<br>
				<u>2470 St.Rose Pkwy, Suite 304<br>
				</u>(Address of Principal Executive Offices)&nbsp;&nbsp;&nbsp;&nbsp; (Zip Code)<br>
				<br>
				<u>(506) 872-4033<br>
				</u>(Registrant's Telephone Number, Including Area Code)<br>
				<br>
				<u>(SELLCELL.NET) 514-1540 West 2nd Ave, Vancouver, BC, V6J 1H2<br>
				</u>(Former Name or Former Address, if Changed Since Last Report)<br>
				<br>
				<br>
			</p>
		</div>
		<div align="left">
			<p>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions.<br>
				<br>
				[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR240.14d-2(b))<br>
				<br>
				[_] Soliciting material pursuant to Rule 14a-12 under Exchange Act (17 CFR240.14a-12)<br>
				<br>
				[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR240.14d-2(b))<br>
				<br>
				[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR240.13e-4(c))<br>
				<br>
				<br>
				<br>
				<br>
				<br>
				<br>
			</p>
		</div>
		<hr>
		<br>
		<br>
		<br>
		<br>
		<b>SECTION 8 &#150; OTHER EVENTS<br>
		</b><b>Item 8.01. Other Events<br>
			<br>
		</b>On January 8, 2007, the Registrant issued a press release announcing that it has retained ZA Consulting for investor relations and financial communications needs, a copy of the Press Release is attached as Exhibit 99.1.&nbsp; <br>
		<br>
		The foregoing description is qualified in its entirety by reference to the Registrant&rsquo;s Press Release dated January 8, 2007, a copy of which is attached hereto as Exhibit 99.1.<br>
		<br>
		<br>
		<b>SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS<br>
			Item 9.01. Financial Statements and Exhibits<br>
			<br>
		</b>(a)&nbsp;&nbsp; Financial Statements of business acquired.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Not applicable<br>
		(b)&nbsp;&nbsp; Pro forma financial information.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not applicable<br>
		(c)&nbsp;&nbsp; Exhibits<br>
		<br>
		Exhibit 99.1&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Press Release of Registrant dated January 8, 2007<br>
		<br>
		<br>
		<p><b>SIGNATURES<br>
				<br>
			</b>Pursuant to the requirements of the Securities Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.<br>
			<br>
			&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BodyTel Scientific Inc.<br>
			<br>
			&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; By:<u> /s/ Benny Lee&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>
			</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;President and CEO<br>
			<br>Date:&nbsp; January 9, 2007<br>
			<br>
			<br>
			<br>
			<br>
			<br>
			<br>
			<br>
			<br>
			<br>
			<br>
			<br>
			<br>
			<br>
			<br>
			<br>
			<br>
		</p>
		<div align="center">
			<p>2</p>
		</div>
		<hr>
	</body>

</html>
[{"type": "8-K", "sequence": "1", "filename": "bodytel8k010807.htm", "description": "BODYTEL SCIENTIFIC (FORMERLY SELLCELL.NET) 8K, 01.08.07", "secsgml_size_bytes": 6181}]
{"company-data": {"conformed-name": "BODYTEL SCIENTIFIC INC.", "cik": "0001341259", "assigned-sic": "3661", "irs-number": "000000000", "state-of-incorporation": "NV", "fiscal-year-end": "0831"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-51633", "film-number": "07520436"}, "business-address": {"street1": "2470 ST. ROSE PARKWAY", "street2": "SUITE 304", "city": "HENDERSON", "state": "NV", "zip": "89074", "phone": "506-872-4033"}, "mail-address": {"street1": "2470 ST. ROSE PARKWAY", "street2": "SUITE 304", "city": "HENDERSON", "state": "NV", "zip": "89074"}, "former-company": {"former-conformed-name": "sellcell.net", "date-changed": "20051012"}}
Untitled Page
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________
FORM 8-K
_________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): January 8, 2007
BODYTEL SCIENTIFIC INC.
(Exact Name of Registrant as Specified in Its Charter)
Nevada
(State or Other Jurisdiction of Incorporation)
000-51633
98-0461698
(Commission File Number)                       (IRS Employer Identification No.)
2470 St.Rose Pkwy, Suite 304
(Address of Principal Executive Offices)     (Zip Code)
(506) 872-4033
(Registrant's Telephone Number, Including Area Code)
(SELLCELL.NET) 514-1540 West 2nd Ave, Vancouver, BC, V6J 1H2
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions.
[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR240.14d-2(b))
[_] Soliciting material pursuant to Rule 14a-12 under Exchange Act (17 CFR240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR240.13e-4(c))
SECTION 8 – OTHER EVENTS
Item 8.01. Other Events
On January 8, 2007, the Registrant issued a press release announcing that it has retained ZA Consulting for investor relations and financial communications needs, a copy of the Press Release is attached as Exhibit 99.1.
The foregoing description is qualified in its entirety by reference to the Registrant's Press Release dated January 8, 2007, a copy of which is attached hereto as Exhibit 99.1.
SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS
Item 9.01. Financial Statements and Exhibits
(a)   Financial Statements of business acquired.        Not applicable
(b)   Pro forma financial information.                        Not applicable
(c)   Exhibits
Exhibit 99.1           Press Release of Registrant dated January 8, 2007
SIGNATURES
Pursuant to the requirements of the Securities Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
BodyTel Scientific Inc.
By:
/s/ Benny Lee
President and CEO
Date:  January 9, 2007
2